NCT05701007 2026-01-29
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
Completed
Clinical Trials
13 trialsNCT03703778 2025-05-06
READT
Chinese University of Hong Kong
Active not recruiting
NCT02588404 2024-12-10
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient
Sir Mortimer B. Davis - Jewish General Hospital
Withdrawn
NCT02366494 2024-11-25
Micro RNAs to Predict Response to Androgen Deprivation Therapy
Medical College of Wisconsin
Completed
NCT03990194 2024-10-31
LEPTO
RECORDATI GROUP
Withdrawn
NCT04897958 2023-07-27
Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data
Brigham and Women's Hospital
Completed
NCT03996993 2019-06-25
Defining Recurrent Disease With Axuminâ„¢
Cancer Center of Irvine
Unknown
NCT03209492 2019-04-11
Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"
Takeda
Completed
NCT02167893 2017-03-29
Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"
Takeda
Completed
NCT02128334 2016-08-16
An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation
Astellas Pharma Inc
Completed
NCT01793077 2014-01-13
TREMODI
Astellas Pharma Inc
Completed
NCT01081873 2012-10-31
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer
Abbott
Completed
NCT01078545 2012-01-16
LEMON
Abbott
Completed